Researchers use nanotechnology to fight breast cancer

Researchers use nanotechnology to fight breast cancer

October is Breast Cancer Awareness Month, an annual campaign to increase awareness of the disease and the importance of early detection. Researchers at the University of Notre Dame are conducting innovative research aimed at improvements in early detection by molecular imaging.

Professors Ryan K. Roeder and Tracy Vargo-Gogola are combining their expertise in biomedical engineering and cancer biology, respectively, through the Harper Cancer Research Institute, a partnership between Notre Dame and the Indiana University School of Medicine-South Bend, to improve the accuracy of mammography for diagnosing .

"Early detection is the most proven means to beat breast cancer," Roeder said. "Mammography is very effective, but not perfect. A specific challenge that has received increased attention in the last few years is that some women have higher density, which can mask abnormalities from being detected by mammography. To make matters worse, women with higher breast are more likely to get breast cancer. Numerous states have now passed legislation requiring that is reported to women who receive mammograms, and federal legislation was recently introduced."

Roeder and Vargo-Gogola's proposed approach is to deliver a radiographic contrast agent that is able to target abnormalities in breast tissue so that they can be seen by mammography even in dense breast tissue.

"The contrast agent uses gold nanoparticles which have molecules attached that target microcalcifications, which are associated with breast cancer, or antibodies which target tumors themselves," he said. "This approach would not be done for screening of the general population but for follow-up or high-risk sub-populations. For example, a woman with suspicious findings on a conventional mammogram could receive the contrast agent and a follow-up mammogram to either rule out a false positive, which spares the woman the stress and anxiety of a biopsy procedure, or confirm a true positive with a more sensitive technique. The method could also be particularly helpful for women at high risk based on or genetic screening."

The research recently received funding from the Kelly Cares Foundation and the Saint Joseph Health System.

"We have successfully demonstrated the approach in several preclinical, animal studies," Roeder said. "The funding we just received from the Kelly Cares Foundation will allow us to investigate feasibility in human-scale models and imaging instrumentation at the Saint Joseph Regional Medical Center in order to build a case for pursuing a clinical trial."

Although early results of the research have shown that much smaller lesions are being detected using the approach, Roeder and Vargo-Gogola caution that more research remains to be done.

"A clinical trial is realistically at least two years away, and if successful, patients would not widely benefit for at least several more years," Roeder said. "Unfortunately, research is very costly and time-consuming, but the potential pay-off is immeasurable if we can save more lives."

Explore further

New approach to mammograms could improve reliability

Citation: Researchers use nanotechnology to fight breast cancer (2015, October 8) retrieved 14 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments